Who is sponsoring NCT05425771?

NCT05425771 is sponsored by Klinikum Garmisch-Patenkirchen.

What drugs are being tested in NCT05425771?

Interventions in NCT05425771: Anti Reflux Mucosa Ablation.

What condition does NCT05425771 study?

NCT05425771 studies Gastro-esophageal Reflux, Reflux, Gastroesophageal.

Is NCT05425771 still recruiting?

NCT05425771 is currently status unknown. Last updated 14 July 2022.

Last reviewed 2022-07-14 · How we verify

NCT05425771: ARMA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

ARMA (Antireflux Mucosa Ablation) in Patients With Chronic Refractory Reflux Disease

Status unknown NA Last updated 14 July 2022

What this trial tests

NA trial testing Anti Reflux Mucosa Ablation in Gastro-esophageal Reflux in 15 participants. Status unknown.

Timeline

14 July 2022

Primary endpoint
31 December 2022

31 May 2023

Quick facts

Lead sponsor	Klinikum Garmisch-Patenkirchen
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	sequential
Masking	none
Primary purpose	treatment
Enrollment	15
Start date	14 July 2022
Primary completion	31 December 2022
Estimated completion	31 May 2023
Sites	1 location across Germany

Drugs / interventions tested

Anti Reflux Mucosa Ablation

Conditions studied

Gastro-esophageal Reflux — all drugs for Gastro-esophageal Reflux →
Reflux, Gastroesophageal — all drugs for Reflux, Gastroesophageal →

Sponsor

Klinikum Garmisch-Patenkirchen

Who can join

Adults 18 to 85, any sex, with Gastro-esophageal Reflux or Reflux, Gastroesophageal. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Pilot study of the possible clinical response to anti reflux mucosal ablation in patients with chronic refractory reflux disease

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05425771 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Klinikum Garmisch-Patenkirchen
Last refreshed: 14 July 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05425771.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing